Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody

Fig. 1

Kaplan-Meier curves indicating estimated proportion of patients not yet showing a poor outcome (defined as a composite of disease progression or death) versus follow-up days, stratified by ICU admission at the time of anti-Ro52 antibody testing. Admission to an ICU was associated with a higher risk of poor outcome (HR 12.97, 95% CI 5.07–34.0, p < 0.0001), whereas presence of any rheumatologic symptom or high titer ANA > = 1:320 were associated with a lower risk of poor outcome (HR 0.4, 95% CI 0.16–0.97, p = 0.04, and HR 0.29, 95% CI 0.09–0.81, p = 0.03, respectively)

Back to article page